Literature DB >> 3936721

Interleukin 2 mRNA induction in human lymphocytes: analysis of the synergistic effect of a calcium ionophore A23187 and a phorbol ester.

Y Yamamoto, T Ohmura, K Fujimoto, K Onoue.   

Abstract

Induction of interleukin 2 (IL2) mRNA in human tonsillar lymphocytes under various conditions was examined by cytoplasmic dot hybridization using a 32P-labeled IL2 cDNA probe to study the signal transduction mechanisms which lead to IL2 gene expression. A tumor-promoting phorbol ester, 12-O-tetradecanoyl-phorbol 13-acetate (TPA), acted synergistically with a Ca2+ ionophore A23187 or phytohemagglutinin (PHA) to induce a high level of IL2 mRNA in lymphocytes, whereas each of them by itself could not induce the mRNA production. In two-step culture experiments the lymphocytes pulse-incubated with TPA for 1 h (the first culture) could efficiently initiate IL2 mRNA production by subsequent culture with A23187 or PHA (the second culture). Results obtained by removal of extracellular Ca2+ from either the first or second culture revealed that Ca2+ was not necessarily required during the first culture with TPA, but it is essential in the second culture with A23187 or PHA, regardless of the presence or absence of Ca2+ in the first culture. A reagent known to be a calmodulin antagonist, N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7), almost completely inhibited the IL2 mRNA induction in A23187-TPA-stimulated lymphocytes at a concentration of 25 microM, whereas N-(6-aminohexyl)-1-naphthalenesulfonamide that has much lower affinity for calmodulin than W-7 did not inhibit at this concentration. The IL2 mRNA induction was also blocked by the addition of 50 microM of 8-(N,N-diethylamino)-octyl-3,4,5-trimethoxybenzoate hydrochloride which is known to block the release of Ca2+ from intracellular storage sites. These results show that mobilization of Ca2+ and the calmodulin-dependent regulatory system appear to work synergistically with TPA which probably activates protein kinase C in the pathway to IL2 gene expression.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3936721     DOI: 10.1002/eji.1830151212

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

1.  Rapid enhancement of beta 2-interferon/B-cell differentiation factor BSF-2 gene expression in human fibroblasts by diacylglycerols and the calcium ionophore A23187.

Authors:  P B Sehgal; Z Walther; I Tamm
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

2.  Mechanisms underlying T-lymphocyte activation: mitogen initiates and IL-2 amplifies the expression of transferrin receptors via intracellular iron level.

Authors:  E Pelosi-Testa; P Samoggia; G Giannella; E Montesoro; T Caravita; G Salvo; A Camagna; G Isacchi; U Testa; C Peschle
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

3.  Unfractionated human thymocytes have a lower proliferative capacity than CD3-4-8- ones but have a similar capacity for expression of interleukin 2 receptors and production of interleukin 2.

Authors:  J Vives; J Solé; B Suarez
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

4.  Perforin is present only in normal activated Lyt2+ T lymphocytes and not in L3T4+ cells, but the serine protease granzyme A is made by both subsets.

Authors:  J A Garcia-Sanz; G Plaetinck; F Velotti; D Masson; J Tschopp; H R MacDonald; M Nabholz
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

5.  A new gene, BCM, on chromosome 16 is fused to the interleukin 2 gene by a t(4;16)(q26;p13) translocation in a malignant T cell lymphoma.

Authors:  Y Laâbi; M P Gras; F Carbonnel; J C Brouet; R Berger; C J Larsen; A Tsapis
Journal:  EMBO J       Date:  1992-11       Impact factor: 11.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.